FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Reco analystes Frazier Lifesciences Acquisition Corporation

Actions

NAMS

NL00150012L7

Recherche biotechnologique et médicale

Temps réel estimé Tradegate 11:34:40 26/08/2026			Varia. 5j.	Varia. 1 janv.
23,46 ^EUR	-14,19%		+0,33%	-22,06%

14/08	NewAmsterdam Pharma Company N.V. annonce des changements au sein de sa direction	CI
06/08	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets reste à l'achat	ZM

Reco analystes

06/08	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets reste à l'achat	ZM
21/07	Frazier Lifesciences Acquisition Corporation : BMO Capital optimiste sur le dossier	ZM
30/06	L'obicetrapib de NewAmsterdam Pharma pourrait gagner des parts de marché, selon RBC Capital Markets	MT
30/06	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets optimiste sur le dossier	ZM
19/03	Frazier Lifesciences Acquisition Corporation : Truist Securities persiste à l'achat	ZM
21/01	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets toujours positif	ZM
06/11	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets toujours positif	ZM
25/08/25	Frazier Lifesciences Acquisition Corporation : Wells Fargo Securities reste à l'achat	ZM
07/08/25	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets toujours positif	ZM
17/07/25	Frazier Lifesciences Acquisition Corporation : Goldman Sachs neutre sur le dossier	ZM
17/06/25	Frazier Lifesciences Acquisition Corporation : Citigroup relève sa recommandation à acheter	ZM
10/06/25	Frazier Lifesciences Acquisition Corporation : Opinion positive de Stifel Nicolaus	ZM
04/06/25	Frazier Lifesciences Acquisition Corporation : Cantor Fitzgerald persiste à l'achat	ZM
30/12/24	Frazier Lifesciences Acquisition Corporation : HC Wainwright optimiste sur le dossier	ZM
15/05/24	Frazier Lifesciences Acquisition Corporation : TD Cowen toujours positif	ZM
14/03/24	Frazier Lifesciences Acquisition Corporation : Scotiabank réajuste son opinion à la hausse	ZM
29/02/24	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets toujours positif	ZM
18/01/24	Frazier Lifesciences Acquisition Corporation : Guggenheim optimiste sur le dossier	ZM
30/10/23	Frazier Lifesciences Acquisition Corporation : RBC Capital Markets maintient sa recommandation à l'achat	ZM
03/04/23	Frazier Lifesciences Acquisition Corporation : Opinion positive de Credit Suisse	ZM
06/01/23	Frazier Lifesciences Acquisition Corporation : Credit Suisse toujours positif	ZM
20/12/22	Frazier Lifesciences Acquisition Corporation : SVB Securities LLC favorable sur le dossier	ZM
20/12/22	Frazier Lifesciences Acquisition Corporation : SVB Securities LLC persiste à l'achat	ZM
19/12/22	Frazier Lifesciences Acquisition Corporation : William Blair & Co. réitère son opinion positive sur le titre	ZM
19/12/22	Frazier Lifesciences Acquisition Corporation : Jefferies & Co. toujours à l'achat	ZM